Shares outstanding · 2019–2025

Novo Nordisk A S shares outstanding

4.4B+0.1% · FY2025

Novo Nordisk A S (NVO) reported 4.4B in shares outstanding for fiscal 2025, +0.1% year on year.

2.4B20192.4B20204.6B20214.5B20224.5B20234.4B20244.4B2025
Novo Nordisk A S — Shares outstanding, 2019–2025
Fiscal yearShares outstandingChangeFiling
FY20252025-12-314.4B+0.1%Open →
FY20242024-12-314.4B−0.4%Open →
FY20232023-12-314.5B−0.9%Open →
FY20222022-12-314.5B−2.6%Open →
FY20212021-12-314.6B+96.6%Open →
FY20202020-12-312.4B−2.1%Open →
FY20192019-12-312.4B—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +10.8%

Figures are reported under IFRS in DKK and converted to US dollars at ECB reference rates — fiscal 2025 average 6.605 DKK/$ for income items, year-end 6.357 DKK/$ for balance-sheet items.

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Novo Nordisk A S shares outstanding |url=https://companiesranked.com/en/company/novo-nordisk-a-s/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Novo Nordisk A S shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/novo-nordisk-a-s/shares-outstanding

BibTeX

@misc{companiesranked-en-company-novo-nordisk-a-s-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Novo Nordisk A S shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/novo-nordisk-a-s/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0000353278-26-000012 · February 4, 2026

{{cite web |title=Novo Nordisk A S shares outstanding — 20-F (0000353278-26-000012) |url=https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Novo Nordisk A S overview